MedTrace Logo

Polyamine-enriched Diet in Elderly Individuals With Subjective Cognitive Decline

NCT03094546 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-04-26

No results posted yet for this study

Summary

The overall objective of this study is to examine the effect of polyamine supplementation on cognitive performance and further characterization of individuals with subjective cognitive decline.

Conditions

  • Subjective Cognitive Decline (SCD)

Interventions

DIETARY_SUPPLEMENT

Polyamine

12 months of polyamine supplementation (6 capsules/day)

DIETARY_SUPPLEMENT

Placebo

12 months of placebo intake (6 capsules/day)

Sponsors & Collaborators

  • Freie Universität, Institute of Biology/Genetic, Berlin, Germany

    collaborator UNKNOWN

  • Karl-Franzens-Universität, Institute of Molecular Biosciences, Graz, Austria

    collaborator UNKNOWN

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Agnes Floeel, Prof · Charité - Universitätsmedizin Berlin, Greifswald Universitätsmedizin

  • Dietmar Schmitz, Prof · Charite University, Berlin, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2020-05-31
Completion
2020-10-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03094546 on ClinicalTrials.gov